Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berchuck

Showing results (151-160 of 681) with videos related to

Pageof 69
Sort By:
Journal of Surgical Case Reports|January 4, 2021
Surgical management of ovarian carcinosarcoma with inferior vena cava extension into the right atriumAkeel M Merchant, Mark D Friedland, Marcus A Behrens, et al.
Gynecologic Oncology|January 1, 1990
Treatment of endometrial stromal tumorsA Berchuck, S C Rubin, W J Hoskins, et al.
Obstetrics and Gynecology|October 1, 1995
Relationship between race and interval to treatment in endometrial cancerJ R Liu, M Conaway, G C Rodriguez, et al.
Obstetrics and Gynecology|May 1, 1993
Mutation and overexpression of p53 in early-stage epithelial ovarian cancerM F Kohler, B J Kerns, P A Humphrey, et al.
Cancer|January 15, 1993
Growth regulation and transformation of ovarian epitheliumA Berchuck, M F Kohler, M P Boente, et al.
Obstetrics and Gynecology|June 1, 1988
Treatment of uterine leiomyosarcomaA Berchuck, S C Rubin, W J Hoskins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2003
Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancerRobert M Wenham, Joellen M Schildkraut, Kia McLean, et al.
Obstetrics and Gynecology|November 25, 2010
Projecting the need for gynecologic oncologists for the next 40 yearsAmy H Wallace, Laura J Havrilesky, Fidel A Valea, et al.
American Journal of Obstetrics and Gynecology|April 1, 1993
A randomized trial of low-dose heparin and intermittent pneumatic calf compression for the prevention of deep venous thrombosis after gynecologic oncology surgeryD L Clarke-Pearson, I S Synan, R Dodge, et al.
Gynecologic Oncology|January 22, 2005
High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancerRobyn A Sayer, Johnathan M Lancaster, Jennifer Pittman, et al.
Pageof 69

Showing results (151-160 of 681) with videos related to

Sort By:
Pageof 69
Journal of Surgical Case Reports|January 4, 2021
Surgical management of ovarian carcinosarcoma with inferior vena cava extension into the right atriumAkeel M Merchant, Mark D Friedland, Marcus A Behrens, et al.
Gynecologic Oncology|January 1, 1990
Treatment of endometrial stromal tumorsA Berchuck, S C Rubin, W J Hoskins, et al.
Obstetrics and Gynecology|October 1, 1995
Relationship between race and interval to treatment in endometrial cancerJ R Liu, M Conaway, G C Rodriguez, et al.
Obstetrics and Gynecology|May 1, 1993
Mutation and overexpression of p53 in early-stage epithelial ovarian cancerM F Kohler, B J Kerns, P A Humphrey, et al.
Cancer|January 15, 1993
Growth regulation and transformation of ovarian epitheliumA Berchuck, M F Kohler, M P Boente, et al.
Obstetrics and Gynecology|June 1, 1988
Treatment of uterine leiomyosarcomaA Berchuck, S C Rubin, W J Hoskins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2003
Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancerRobert M Wenham, Joellen M Schildkraut, Kia McLean, et al.
Obstetrics and Gynecology|November 25, 2010
Projecting the need for gynecologic oncologists for the next 40 yearsAmy H Wallace, Laura J Havrilesky, Fidel A Valea, et al.
American Journal of Obstetrics and Gynecology|April 1, 1993
A randomized trial of low-dose heparin and intermittent pneumatic calf compression for the prevention of deep venous thrombosis after gynecologic oncology surgeryD L Clarke-Pearson, I S Synan, R Dodge, et al.
Gynecologic Oncology|January 22, 2005
High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancerRobyn A Sayer, Johnathan M Lancaster, Jennifer Pittman, et al.
Pageof 69